VNRX Latest Press Releases

-- October 27, 2026 --

VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide PRNewswire 8:48 AM

VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash PRNewswire 8:18 AM

-- September 17, 2026 --

VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France PRNewswire 9:18 AM

VolitionRx Participates in Launch of DETECSEPS Program in France PRNewswire 8:17 AM

-- September 14, 2026 --

VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 PRNewswire 8:17 AM

-- September 10, 2026 --

Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference PRNewswire 8:18 AM

-- August 26, 2026 --

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets PRNewswire 9:17 AM

Volition Announces Landmark Clinical Validation of Nu.Q NETs Biomarker in Sepsis PRNewswire 8:18 AM

-- August 13, 2026 --

VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update PRNewswire 4:10 PM

-- August 12, 2026 --

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients PRNewswire 8:17 AM

-- August 11, 2026 --

VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update PRNewswire 4:10 PM

-- August 5, 2026 --

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq Liquid Biopsy Technology PRNewswire 8:17 AM

-- July 30, 2026 --

Volition Advances Nu.Q NETs Platform Towards Commercialization PRNewswire 8:17 AM

-- July 7, 2026 --

VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q Cancer Test PRNewswire 8:17 AM

-- June 17, 2026 --

VolitionRx Announces Collaboration with Sysmex PRNewswire 8:15 AM

Market Data Delayed 15 Minutes